Albany Molecular Research Inc (NASDAQ:AMRI)

19.92
Delayed Data
As of Jul 02
 +0.17 / +0.86%
Today’s Change
13.73
Today|||52-Week Range
23.95
+22.36%
Year-to-Date
No recent news for Albany Molecular Research Inc.

Today’s Trading

Previous close19.75
Today’s open19.83
Day’s range19.77 - 20.09
Volume295,797
Average volume (3 months)427,166
Market cap$659.7M
Dividend yield--
Data as of 3:59pm ET, 07/02/2015

Growth & Valuation

Earnings growth (last year)-125.00%
Earnings growth (this year)+19.84%
Earnings growth (next 5 years)+12.85%
Revenue growth (last year)+12.17%
P/E ratioNM
Price/Sales1.86
Price/Book2.69

Competitors

 Today’s
change
Today’s
% change
EXELExelixis Inc-0.05-1.43%
SGMOSangamo BioSciences ...-0.19-1.87%
LXRXLexicon Pharmaceutic...+0.15+1.87%
FLXNFlexion Therapeutics...-0.39-1.81%
Data as of 4:00pm ET, 07/02/2015

Financials

Next reporting dateAugust 4, 2015
EPS forecast (this quarter)$0.16
Annual revenue (last year)$276.6M
Annual profit (last year)-$3.3M
Net profit margin-1.19%

Profile

Sector
Health Services
Industry
Services to the Health Industry
President, Chief Executive Officer &
Director
William S. Marth
Chief Financial Officer, Treasurer &
Senior VP
Felicia Ladin
Corporate headquarters
Albany, New York

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers